Browse > Article

A Case of Malignant Intraductal Papillary Mucinous Neoplasm of the Pancreas with Duodenal Adenocarcinoma  

Park, Kyoung-Suk (Departments of Internal Medicine, College of Medicine, Kwandong University)
Cho, Jae-Hee (Departments of Internal Medicine, College of Medicine, Kwandong University)
Park, Tae-Woon (Departments of Internal Medicine, College of Medicine, Kwandong University)
Ko, Geun-Jun (Departments of Internal Medicine, College of Medicine, Kwandong University)
Woo, Myoung-Lyeol (Departments of Internal Medicine, College of Medicine, Kwandong University)
Jeong, Jin-Ho (Department of Surgery, College of Medicine, Kwandong University)
Oh, Hwa-Eun (Department of Pathology, College of Medicine, Kwandong University)
Publication Information
Clinical Endoscopy / v.42, no.4, 2011 , pp. 268-273 More about this Journal
Abstract
Intraductal papillary mucinous neoplasm of the pancreas (IPMN) is a precancerous lesion with a well-described adenocarcinoma sequence. The rate of progression of IPMN appears to be very slow; however, patients with IPMN may be at increased risk for extrapancreatic malignancies. A 55-year-old female was diagnosed with IPMN of the pancreas and a duodenal polyp in 2004. After an approximate 3 year loss to follow-up, she was readmitted for managing abdominal pain and underwent Whipple's operation. Herein, we report a case of a patient with malignant IPMN accompanied by duodenal adenocarcinoma arising from a duodenal polyp.
Keywords
Pancreatic neoplasm; Duodenal neoplasm; Multiple primary neoplasms;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Ohashi K, Murakami Y, Maruyama M. Four cases of mucin producing cancer of the pancreas on specific findings of the papilla of Vater. Prog Dig Endosc 1982;20:348-351.
2 Sessa F, Solcia E, Capella C, et al. Intraductal papillary mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients. Virchows Arch 1994;425:357-367.
3 Z'graggen K, Rivera JA, Compton CC, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997;226:491-498.   DOI   ScienceOn
4 Jiang ZL, Satoh K, Moriizumi S, Shimosegawa T, Koizumi M, Toyota T. An analysis of the diseases associated with mucin-producing tumors of the pancreas. J Jpn Panc Soc 1996;11:289-292.
5 Sugiyama M, Atomi Y. Extrapancreatic neoplasms occur with unusual frequency in patients with intraductal papillary mucinous tumors of the pancreas. Am J Gastroenterol 1999;94:470-473.   DOI   ScienceOn
6 Yamaguchi K, Yokohata K, Noshiro H, Chijiiwa K, Tanaka M. Mucinous cystic neoplasm of the pancreas or intraductal papillary-mucinous tumour of the pancreas. Eur J Surg 2000;166:141-148.   DOI   ScienceOn
7 Suzuki Y, Atomi Y, Sugiyama M, et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004;28:241-246.   DOI   ScienceOn
8 Jang JY, Kim SW, Ahn YJ, et al. Multicenter analysis of clinicopathologic features of intraductal papillary mucinous tumor of the pancreas: is it possible to predict the malignancy before surgery? Ann Surg Oncol 2005;12:124-132.   DOI   ScienceOn
9 Kamisawa T, Tu Y, Egawa N, Nakajima H, Tsuruta K, Okamoto A. Malignancies associated with intraductal papillary mucinous neoplasm of the pancreas. World J Gastroenterol 2005;11:5688-5690.   DOI
10 Choi MG, Kim SW, Han SS, Jang JY, Park YH. High incidence of extrapancreatic neoplasms in patients with intraductal papillary mucinous neoplasms. Arch Surg 2006;141:51-56.   DOI   ScienceOn
11 Eguchi H, Ishikawa O, Ohigashi H, et al. Patients with pancreatic intraductal papillary mucinous neoplasms are at high risk of colorectal cancer development. Surgery 2006;139:749-754.   DOI   ScienceOn
12 Yoon WJ, Ryu JK, Lee JK, et al. Extrapancreatic malignancies in patients with intraductal papillary mucinous neoplasm of the pancreas: prevalence, associated factors, and comparison with patients with other pancreatic cystic neoplasms. Ann Surg Oncol 2008;15:3193-3198.   DOI   ScienceOn
13 Serikawa M, Sasaki T, Fujimoto Y, Kuwahara K, Chayama K. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. J Clin Gastroenterol 2006;40:856-862.   DOI   ScienceOn
14 Tanaka M, Chari S, Adsay V, et al; International Association of Pancreatology. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.   DOI   ScienceOn
15 Wheeler JM, Warren BF, Mortenson NJ, et al. An insight into the genetic pathway of adenocarcinoma of the small intestine. Gut 2002;50:218-223.   DOI   ScienceOn
16 Billroth T. Die allgemeine chirurgische pathologie und therapie in 51 Vorlesungen: ein handbuch fur Studirende und Arzte, 14 Aufl. Berlin, Germany: G. Reimer, 1889.
17 International Association of Cancer Registries. Multiple primaries internal report No. 00/003. Lyon: IARC, 2000.
18 Slaughter DP, Southwick HW, smejkal W. Field cancerization in oral stratified squamous epithelium; clinical implication of multicentric origin. Cancer 1953;6:963-968.   DOI   ScienceOn
19 Abrahams NA, Halverson A, Fazio VW, Rybicki LA, Goldblum JR. Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors. Dis Colon Rectum 2002;45:1496-1502.   DOI   ScienceOn
20 Ahn YJ, Jang JY, Lee SE, et al. Germline genetic alterations in intraductal papillary neoplasms associated with extrapancreatic tumors. J Korean Surg Soc 2009;76:236-245.   DOI   ScienceOn